Recent evidence suggests NAPDH oxidases-4 (NOX4) and AMP-activated protein kinase (AMPK) as potential therapeutic targets in PF (Amara et al., 2010; Li et al., 2015). The gene discussed is NOX4; the disease is pemphigus foliaceus.